tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Genmab A/S (GB:0MGB)
LSE:0MGB
UK Market
0MGB
Genmab A/S
Overview
Analyst Forecasts
News & Insights
Financials
Dividends
Technical Analysis
Chart
Earnings
Historical Prices
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Genmab A/S (0MGB) Stock News & Sentiment

Compare
10 Followers
Genmab A/S Faces Sell Rating Amid Hexabody Setbacks and Darzalex Patent Concerns
Premium
Ratings
Genmab A/S Faces Sell Rating Amid Hexabody Setbacks and Darzalex Patent Concerns
16h ago
GMAB
Genmab’s Promising Oncology Prospects and Strategic Growth Catalysts Highlighted in Buy Rating
Premium
Ratings
Genmab’s Promising Oncology Prospects and Strategic Growth Catalysts Highlighted in Buy Rating
15d ago
GMAB
Genmab’s Promising Pipeline and Strategic Focus Justify Buy Rating Despite GEN3014 Setback
Premium
Ratings
Genmab’s Promising Pipeline and Strategic Focus Justify Buy Rating Despite GEN3014 Setback
20d ago
GMAB
Genmab A/S Navigates Global Economic and Geopolitical Challenges Amidst Market Volatility
Premium
Company Announcements
Genmab A/S Navigates Global Economic and Geopolitical Challenges Amidst Market Volatility
2M ago
Genmab A/S (0MGB) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Genmab A/S (0MGB) Q4 Earnings Cheat Sheet
2M ago
Genmab A/S’ New Regulation Risk – A Cause for Worry?
Premium
Market News
Genmab A/S’ New Regulation Risk – A Cause for Worry?
1y ago
Genmab A/S (0MGB) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Genmab A/S (0MGB) Q4 Earnings Cheat Sheet
1y ago
More GB:0MGB News >

0MGB News on the Web

JPMorgan expects 'significant' underperformance of Genmab shares
The Fly
Neutral
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
Yahoo Finance
Neutral
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Yahoo Finance UK
Neutral
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Yahoo Finance UK
Neutral
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
Yahoo Finance UK
Neutral
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Yahoo Finance
Neutral
EPKINLY® Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
Yahoo Finance UK
Neutral
Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
GB:0MGB
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0MGB’s Media Buzz Sentiment?
Currently, no data Available
What is GB:0MGB’s weekly average amount of articles?
Currently, no data Available
What is GB:0MGB’s News Sentiment?
59% of articles about GB:0MGB were positive this week, compared to its sector average of 57%.
    Healthcare Stocks that are Trending in the News
    SLNOSoleno Therapeutics
    CORTCorcept Therapeutics
    GRDNGuardian Pharmacy Services, Inc. Class A
    BKDBrookdale Senior Living
    COYACoya Therapeutics, Inc.
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing